Abstract: To determine whether a subset of primary extramammary Paget disease (EMPD) may originate in anogenital mammary-like glands (AGMLG), the authors studied 181 specimens of EMPD, detailing alterations in AGMLG. The latter were identified in 33 specimens from 31 patients. All patients were women, ranging in age from 38 to 93 years (median, 65 y). In all cases, lesions involved the vulva and in 1 patient the perianal skin was affected. Histopathologically, AGMLG manifested changes identical to columnar cell change (CCC) (87.1%), usual ductal hyperplasia (22.6%), columnar cell hyperplasia (CCH) (9.7%), oxyphilic (apocrine) metaplasia (6.5%), and atypical duct hyperplasia (3.2%). Four cases (12.9%), in addition to intraepidermal carcinoma, harbored invasive carcinoma. In all 4 of these, AGMLG displayed a range of alterations including ductal carcinoma in situ, CCC, and CCH. Three further cases (9.7%) showed ductal carcinoma in situ without any definite invasive carcinoma. Colonization of AGMLG by neoplastic Paget cells was noted in 6 cases. As CCC and CCH may be encountered in normal AGMLG, these alterations are unlikely to play a significant role in the pathogenesis of the disease. However, by analogy with mammary Paget disease, rare cases of primary EMPD may originate in AGMLG with a subsequent upward migration of the neoplastic cells into the epidermis and possible later breach through the basal membrane. Usual ductal hyperplasia and atypical duct hyperplasia can then be regarded as earlier precursor lesions, linking both ends of the spectrum.
xtramammary Paget disease (EMPD) is a rare neoplasm usually involving the anogenital area, most commonly the vulva. 1 EMPD can be divided into primary and secondary forms, the latter representing intraepithelial spread of an underlying carcinoma arising in the urogenital or gastrointestinal tracts. [2] [3] [4] [5] The histogenesis of primary EMPD is uncertain. Cutaneous adnexa, clear cells of Toker, pluripotent stem cells, and anogenital mammary-like glands (AGMLG) have been proposed as possible sites of origin. 2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Unlike in mammary Paget disease (MPD), underlying ductal carcinoma in situ (DCIS) or invasive mammary-type carcinoma are rarely associated with primary EMPD, 2, [19] [20] [21] but, when present, they raise the likelihood that the pathogenesis of EMPD in these cases may be identical to that of MPD. 2 In addition to DCIS, AGMLG in cases of primary EMPD may show changes identical to those affecting ducts in the breast, including columnar cell change (CCC), columnar cell hyperplasia (CCH), usual ductal hyperplasia (UDH), and atypical duct hyperplasia (ADH). 2, 7 Further, AGMLG may represent a path for carcinomatous spread into deeper tissues. 2, 7, 22 The goals of our study were to identify and describe the spectrum of involvement of AGMLG and their ducts in cases of primary anogenital EMPD, and to determine whether a subset of primary EMPD may originate in AGMLG, analogous to breast carcinoma.
MATERIALS AND METHODS

Case Selection
A search in the consultation, routine institutional, and personal files of the authors between 1993 and 2016 years yielded 202 cases coded as EMPD. Histologic slides were reviewed along with the available clinical information obtained from patients' medical records to confirm the location and the clinicopathologic context. Only cases of primary anogenital EMPD were included. Excluded from the study were 21 cases of secondary EMPD arising from carcinomas of other primary sites (rectum, urethra, prostate, etc.) and cases with insufficient clinical data.
Light Microscopy
The study was based on the assessment of hematoxylin and eosin-stained slides. All specimens were local resections, wide surgical excisions, or vulvectomies. We determined the presence and nature of involvement of AGMLG and their ducts in 181 specimens from 150 patients. Of the 181 specimens, 102 were wide surgical excisions, local resections, or vulvectomies (the number of tissue blocks ranged from 1 to 59; median, 10) and 79 were small specimens (punch, or small incisional biopsies, with a single block per case).
The following features were assessed using the same criteria applied in breast pathology [23] [24] [25] : oxyphilic metaplasia, CCC, CCH, UDH, ADH, DCIS, and colonization of AGMLG by carcinoma cells. Oxyphilic metaplasia manifests as cells with eosinophilic, glassy cytoplasm, which may have mildly pleomorphic nuclei and conspicuous nucleoli. CCC presents as variably dilated lumina lined by 1 to 2 layers of columnar epithelial cells oriented perpendicularly to the basement membrane and which have apical cytoplasmic blebs or snouts. CCH has variably dilated lumina lined by >2 layers of columnar epithelial cells as described for CCC. UDH shows solid or fenestrated intralumimal streaming cellular proliferation without atypia. ADH was defined as a marked intraluminal proliferation of uniform cuboidal epithelial cells with increased nuclear to cytoplasmic ratio, forming complex architectural patterns including micropapillae, true papillae, cribriform spaces with Roman bridges but with mild or no cytologic atypia. 2 DCIS was defined according to Rosai, including papillary, comedocarcinoma, solid, cribriform, micropapillary, clinging, and cystic hypersecretory variants. 23 Grading of DCIS of AGMLG was according to published criteria. 26 For EMPD having both invasive carcinoma and DCIS, grading of the invasive carcinoma was performed according to the Nottingham system (Elston-Ellis modification of Scarff-Bloom-Richardson grading system). 25 All the specimens were reviewed by a general pathologist (A.M.K.), dermatopathologist (D.V.K.), and an expert in mammary pathology (M.M.). The number of tissue blocks with changes in AGMLG ranged from 1 to 12 (median, 3) per case. All patients were women, ranging in age from 38 to 93 years (median, 65 y; mean, 64.2 y). The age of the patients was unknown in 2 cases.
All included patients were the subjects of previous publications addressing various other clinicopathologic aspects of AGMLG and EMPD. 7, 22, [27] [28] [29] 
RESULTS
The main clinical and morphologic findings are summarized in Table 1 . All lesions involved the vulva other than 1 case of UDH in the perianal skin. Alterations of AGMLG were found in 33 specimens from 31 patients. In 29 cases, the carcinoma was confined to the epidermis (in situ), whereas in the remaining 4 there was stromal microinvasion defined as invasion to a depth of no >1mm. 30 The most common change encountered in AGMLG was CCC (87.1%) (Fig. 1) . Less frequently found were UDH (22.6%), CCH (9.7%), oxyphilic (apocrine) metaplasia (6.5%), and ADH (3.2%) (Figs. 2-4 ). Four cases (12.9%), in addition to intraepidermal carcinoma, harbored invasive carcinoma resembling breast carcinoma (3 with invasive carcinoma of no special type [NST] [previously known as ductal carcinoma]; 1 with a tubulolobular carcinoma). In all 4 cases AGMLG displayed a range of changes including DCIS (1 case), CCC (2 cases), and CCC combined with CCH (1 case) (Figs. 5, 6 ). In a further 3 cases (9.7%), DCIS without definite invasion was recognized. In 2 of these, adjacent to DCIS were areas of fibrosis and elastosis, as may be found in mammary invasive carcinoma, NST (Fig. 7) . DCIS morphology included solid growth with or without comedonecrosis or a micropapillary pattern, and was of grade 2 to 3. The invasive carcinomas also were grade 2 or 3. Colonization of AGMLG by neoplastic Paget cells was noted in 6 cases (Fig. 8) . In 3, single cells or small clusters of neoplastic cells focally infiltrated the glandular portion of AGMLG. One case each, respectively, showed extensive single cell infiltration of neoplastic cells beneath a preserved luminal layer in an excretory duct, similar extensive single cell infiltration in both glandular and excretory duct elements, and almost complete replacement of normal glandular luminal epithelium by solid and cribriform formations of Paget cells, with a preserved peripheral myoepithelial cell layer, occasioning resemblance to DCIS. In a further case with DCIS, there was also extensive colonization of AGMLG.
DISCUSSION
We found alterations of AGMLG in 33 of 181 specimens (18.2%) although the actual figure may be higher, as some specimens (small biopsies) lacked AGMLG. From our findings, there seems to be a spectrum of ductal lesions ranging from CCC and CCH via UDH/ADH to DCIS and invasive carcinoma. The question is whether this finding allows a bona fide conclusion that a subset of primary EMPD may originate in AGMLG. Although in the breast, low level allelic imbalance was demonstrated in columnar cell lesions, 31 our recent study suggested that CCC and CCH may occur normally in AGMLG, as they were seen in approximately 30% and 10% of cases, respectively. 32 Admittedly, no molecular biological studies were carried out for comparison with the breast data. More remarkable is that CCC in AGMLG in the setting of EMPD is much more frequent than in "normal" AGMLG (87% vs. 33%, respectively). 32 In this series, there were 4 cases of invasive mammary-type carcinomas of AGMLG and 3 cases of DCIS, suggesting that in these cases the carcinoma may have originated in AGMLG, with subsequent upward migration of the neoplastic cells into the epidermis, similar to cases of so-called invasive MPD. 7, 33 In 2 of these cases, there was elastosis near the DCIS that may be a sign of stromal invasion analogous to the situation in the breast in which an invasive carcinoma of NST may elicit prominent elastosis, at times so prominent as to be appreciated grossly as white chalky streaks. If one accepts the occurrence of DCIS and invasive carcinoma as 1 path of tumor progression in EMPD, then UDH and ADH might reasonably be interpreted as precursor lesions.
In contrast, we have previously shown that cutaneous adnexa including hair follicles, sebaceous glands, and apocrine and eccrine units may present a path for carcinomatous spread into deeper tissues in cases of EMPD, as they are involved in almost all cases. 7, 22 A similar situation may be presumed with respect to AGMLG. We noticed several patterns of colonization of AGMLG by neoplastic cells. Both ductal and/ or glandular components were focally or diffusely infiltrated by neoplastic cells with preservation of the normal luminal cells or, as seen in one case, there was almost complete replacement of the normal luminal epithelium by solid or cribriform formations of Paget cells above a preserved peripheral myoepithelial cell layer resembling DCIS. In the latter case, it may be difficult or impossible to determine whether DCIS is the source of the EMPD or the result of colonization of these glands by the neoplastic cells of EMPD. Although we arbitrarily considered single cell spread of Paget cells in AGMLG as colonization, we cannot completely exclude that this may be an incipient (in situ) carcinomatous change within AGMLG or the result of a field effect. One can argue that the similar occurrence in cutaneous adnexa may occasion the same conclusion, but the absence of lesions compatible with DCIS in eccrine/apocrine units and involvement of different adnexa (sebaceous glands, hair follicles, etc.) militate against an adnexal origin.
In conclusion, AGMLG in primary EMPD manifest a range of changes analogous to those occurring in the breast and which may be regarded as a morphologic spectrum. As CCC and CCH may be encountered in normal AGMLG, these alterations would seem to play little, if any, role in the pathogenesis of EMPD. However, DCIS and invasive carcinoma comprising the malignant end of the spectrum suggest, by analogy with some cases of MPD, 33 that rare cases of primary EMPD may originate in AGMLG with subsequent upward migration of the neoplastic cells into the epidermis and possible later breach through the basement membrane. UDH and ADH can then be regarded as precursor lesions, linking both ends of the spectrum. If our proposition is confirmed in subsequent studies, this may result in a reevaluation of current therapeutic approaches to primary EMPD, especially with respect to local surgical and nonsurgical treatment, which should take into consideration both the depth of secondary adnexal involvement (up to 3.6 mm) and the depth of location of AGMLG (up to 3.9 mm) as a possible source of disease, including recurrences, which have a rate that ranges currently from 12% to 57%. 3, 22, 32 FIGURE 5. EMPD associated with underlying mammary-type invasive carcinoma of NST (previously called invasive ductal carcinoma) (A). Note DCIS of micropapillary type (arrows) (B). 
